Electra Therapeutics
PrivateLast Round
Series C
Oct 22, 2025
Est. Valuation
$479M
Total Funding Raised
$267M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Electra Therapeutics is a biotechnology company developing antibody therapies that target signal regulatory proteins to treat immunological diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Electra Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Electra Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 22, 2025 | ||||
| Series B | Feb 16, 2022 |
Electra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series B, Series C |
| RA Capital Management | Series C, Series B |
| New Leaf Venture Partners | Series C, Series B |
| EQT Life Sciences | Series C |
| Westlake Village BioPartners | Series C, Series B |
| Cowen Private Investments | Series B |
| Cormorant Asset Management | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
Presenting at the 44th annual J.P. Morgan Healthcare Conference on January 12, 2026.
- Dec 2, 2025
Presented SURPASS trial design for ELA026 at ASH 2025.
Electra Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Electra Therapeutics's valuation, stock price, and market status.